| Allopurinol to Prevent Cirrhosis Related Morbidities (NCT05545670) | Tanta University | 2022-06-15 |
| Evaluation of Cardiac Function in Acutely Decompensated Cirrhosis (NCT05413083) | Clinical Hospital Colentina | 2022-06-06 |
| Effect of Brief Dietary Intervention on Ammonia Levels (NCT05376488) | Hunter Holmes Mcguire Veteran Affairs Medical Center | 2022-05-01 |
| Vagus Nerve-guided Robotic-assisted Splenectomy and Azygoportal Disconnection (NCT05300516) | Northern Jiangsu People's Hospital | 2022-04-01 |
| Apixaban Prevents Portal Vein Thrombosis After Laparoscopic Splenectomy and Azygoportal Disconnection (NCT05304455) | Northern Jiangsu People's Hospital | 2022-04-01 |
| Impact of Acute Kidney Injury on Sarcopenia and Frailty in Patients With Liver Cirrhosis (NCT05389280) | Kangbuk Samsung Hospital | 2022-03-23 |
| Prospective Cohort for Early Detection of Liver Cancer (NCT05541601) | University of Oxford | 2022-02-23 |
| Extubation Failure in Critically Ill Cirrhotic Patients. (NCT05244005) | University Hospital, Montpellier | 2022-02-01 |
| Effects of Empagliflozin on Fibrosis and Cirrhosis in Chronic Hepatitis B Patients (NCT05147090) | The University of Hong Kong | 2022-01-02 |
| Early Diagnosis and Timely Treatment of Cirrhotic Patients With Minimal Hepatic Encephalopathy (CHESS-NCRCID 2106) (NCT05140837) | Hepatopancreatobiliary Surgery Institute of Gansu Province | 2021-12-09 |
| Durvalumab (MEDI4736) and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver Transplant (NCT05027425) | University of Cincinnati | 2021-12-07 |
| Empagliflozin in Diuretic Refractory Ascites (NCT05013502) | Stanford University | 2021-11-15 |
| A Trial to Improve Quality of Life in People With Cirrhosis (NCT05061992) | University of Michigan | 2021-11-10 |
| EUS vs TJ for Liver Biopsy and Portal Pressure Gradient Measurement (NCT05118308) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2021-11-04 |
| Hepatic Impairment With Cirrhosis Due to Cholestatic Liver Disease (NCT05045482) | Zydus Therapeutics Inc. | 2021-10-21 |
| Decompensation of Cirrhosis and Iron Metabolism (NCT04807023) | Rennes University Hospital | 2021-09-08 |
| Sodium-glucose Linked Transporter 2 (SGLT-2) Inhibitors in Recurrent Ascites: a Pilot RCT (NCT05014594) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2021-09-03 |
| Comparison of the Concentration of Estrogen and Testosterone Ratio in Male Patients With Cirrhosis and Hypotension (NCT05051293) | Methodist Health System | 2021-08-22 |
| VE303 for Treatment of Hepatic Encephalopathy (HE) (NCT04899115) | Patricia Bloom | 2021-08-06 |
| Defining the Mechanisms Underlying Adrenal Insufficiency in Cirrhosis (NCT04642391) | University of Virginia | 2021-08-02 |
| Angiotensin 2 for Hepatorenal Syndrome (NCT04048707) | University of California, Los Angeles | 2021-07-01 |
| Antimicrobial Resistance in Cirrhotic Patients (NCT04915573) | Mansoura University | 2021-06-07 |
| Branched-chain Amino Acid Supplementation for Hepatocellular Carcinoma (NCT03908255) | Louisiana State University Health Sciences Center in New Orleans | 2021-06-01 |
| THE FRENCH NATIONAL NAFLD COHORT (FRench pAtients With MEtabolic Steatosis) (NCT04925362) | Assistance Publique - Hôpitaux de Paris | 2021-06-01 |
| Timing of Endoscopic Intervention for Acute Variceal Hemorrhage: an RCT (NCT04786743) | Jinling Hospital, China | 2021-04-20 |
| Volatile Organic Compounds for the Assessment of Liver Disease (NCT04620538) | Imperial College London | 2021-04-01 |
| Evaluation of Minimal Hepatic Encephalopathy in Patients With Cirrhosis and Portal Hypertension (NCT04807803) | IHU Strasbourg | 2021-03-26 |
| Assessment Of Lipid Profile In Cirrhotic Patients (NCT04788173) | Sohag University | 2021-03-01 |
| Probiotics and Hemodynamic Changes in Cirrhosis (NCT05231772) | I.M. Sechenov First Moscow State Medical University | 2021-03-01 |
| Evaluation of a Nutrition Education Guide for Patients With Cirrhosis (NCT07090447) | Centre hospitalier de l'Université de Montréal (CHUM) | 2021-02-04 |
| The BRAINFOOD Trial to Prevent Recurrent Hepatic Encephalopathy. (NCT04675775) | University of Michigan | 2021-01-21 |
| Non-Pharmaceutical Intervention for Cirrhotic Cramps Reduction: The NICCles Trial (NCT04650295) | University of Michigan | 2021-01-18 |
| Predictive Models of Hepatic Decompensation and Survival Outcomes in Pediatric Patients With Cirrhosis (NCT05181332) | West China Hospital | 2021-01-01 |
| EYE-Mobile TRACKer IN the Diagnosis of Minimal Hepatic Encephalopathy (NCT03732118) | Assistance Publique - Hôpitaux de Paris | 2020-12-18 |
| Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy（ESAWAAPT） (NCT04645550) | Northern Jiangsu People's Hospital | 2020-11-22 |
| Hepatocellular Carcinoma Surveillance in Cirrhotics (NCT04248816) | University of Pennsylvania | 2020-11-19 |
| EUS Guided Portal-systemic Pressure Gradient Measurement (NCT04633356) | Chinese University of Hong Kong | 2020-11-12 |
| Multi-Center Study of the Effects of Simvastatin on Hepatic Decompensation and Death in Subjects Presenting With High-Risk Compensated Cirrhosis (NCT03654053) | VA Office of Research and Development | 2020-10-02 |
| LIFT Intervention in Liver Transplant Candidates (NCT04836923) | Northwestern University | 2020-10-01 |
| Orphenadrine Versus Baclofen in Treatment of Muscle Cramps in Cirrhotic Patients (NCT04509336) | Mansoura University | 2020-08-20 |
| Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrhosis (NCT04365868) | Galectin Therapeutics Inc. | 2020-06-25 |
| A Cross Sectional Study for Determining Prevalence of Sarcopenia and Myosteatosis in Cirrhotic Patients and to Study the Association Between Imaging and Clinical Parameters (NCT05157308) | Asian Institute of Gastroenterology, India | 2020-03-10 |
| Periodontal Therapy and Oral-gut-hepatic Axis Cirrhosis: a Randomized Controlled Trial (NCT04330469) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2020-03-01 |
| Safety of Anticoagulant Therapy After Endoscopic Treatment (NCT04976543) | Qilu Hospital of Shandong University | 2020-02-01 |
| Laparoscopic Splenectomy and Azygoportal Disconnection With Intraoperative Endoscopic Variceal Ligation (NCT04244487) | Northern Jiangsu People's Hospital | 2020-01-03 |
| Doxycycline for the Prevention of Spontaneous Bacterial Peritonitis (NCT04153604) | Methodist Health System | 2019-11-04 |
| PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies (NCT04371042) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2019-09-01 |
| A Study of Oryz-Aspergillus Enzyme and Pancreatin Tablet in Patients With Cirrhosis and Malnutrition (NCT04057326) | Shenzhen Kangzhe Pharmaceutical Co., Ltd. | 2019-08-30 |
| EUS-guided Combined Therapy Versus Beta Blocker Therapy in Primary Prophylaxis o GOV II and IGV I (NCT04075760) | Instituto Ecuatoriano de Enfermedades Digestivas | 2019-08-01 |
| FMT in Cirrhosis and Hepatic Encephalopathy (NCT03796598) | VA Office of Research and Development | 2019-07-29 |
| Liver Resection Modeling (NCT04023136) | Assistance Publique - Hôpitaux de Paris | 2019-07-15 |
| Study of microRNAs in a Decompensated Cirrhosis (NCT03905746) | Hospices Civils de Lyon | 2019-06-26 |
| A Phase III Study to Evaluate Efficacy and Safety of TG-2349 in Combination With DAG181 and RBV for HCV Type I Patients (NCT04155515) | Dongguan HEC TaiGen Biopharmaceuticals Co., Ltd. | 2019-06-13 |
| Microvesicles and Monocytes to Predict Mortality of Patients with Cirrhosis (NCT03837444) | Assistance Publique - Hôpitaux de Paris | 2019-06-12 |
| Abdominal Regional Perfusion in Donation After Cardiac Death for Multi-Organ Transplantation (NCT03946852) | London Health Sciences Centre | 2019-06-01 |
| Probiotics in the Prevention of Hepatocellular Carcinoma in Cirrhosis (NCT03853928) | Austral University, Argentina | 2019-05-01 |
| Microbiota Study in Liver Transplanted Patients (NCT03507140) | University Hospital, Grenoble | 2019-04-16 |
| A Study Evaluating the Utility of Ambrisentan in Lowering Portal Pressure in Patients With Liver Cirrhosis (NCT03827200) | Noorik Biopharmaceuticals AG | 2019-04-11 |
| A Pathophysiological Study of the Postprandial Human Liver (PLS) (NCT03849235) | Copenhagen University Hospital, Hvidovre | 2019-03-02 |
| Propranolol, Carvedilol and Rosuvastatin in the Prevention of Variceal Bleeding in Cirrhotic Portal Hypertension (NCT03720067) | Universidade Federal do Rio de Janeiro | 2019-01-25 |
| Chemotherapy and Liver Cirrhosis in Frequently-associated Cancers (NCT04179773) | University Hospital, Lille | 2019-01-24 |
| "Early TIPS" Versus Glue Obliteration to Prevent Rebleeding From Gastric Varices (NCT03705078) | Centre Hospitalier Universitaire de Besancon | 2019-01-03 |
| Protocol for Muscle Attenuation Cut-offs in Cirrhosis (NCT06593015) | University of Roma La Sapienza | 2019-01-01 |
| A Prospective Study to Monitor Liver Diseases Dynamically by Ultrasound Viscoelasticity (NCT03777293) | Third Affiliated Hospital, Sun Yat-Sen University | 2019-01-01 |
| Restrictive Versus Liberal Red Blood Cell Transfusion in Patients of Cirrhosis With Septic Shock (NCT03433508) | Institute of Liver and Biliary Sciences, India | 2018-12-15 |
| Nalmefene in Patients With Alcoholic Compensated Cirrhosis for the Treatment of Alcohol Dependence. (NCT02824354) | Centre Hospitalier Universitaire, Amiens | 2018-12-01 |
| Study Of Bacterial/Fungal Infections in Hospitalized Patients With Liver Cirrhosis in China (NCT03676777) | Ruijin Hospital | 2018-11-07 |
| Data Collection and Identification of Infection-responsible Bacterial Resistances in Cirrhotic Patients (NCT03965260) | Hospices Civils de Lyon | 2018-11-01 |
| The Impact of Liver Cirrhosis on Outcomes in Trauma Patients (NCT05170854) | Methodist Health System | 2018-10-16 |
| Bacterial Infections in Patients with Cirrhosis in Argentina: Clinical and Microbiological Characteristics (NCT03919032) | Hospital Italiano de Buenos Aires | 2018-10-16 |
| High Versus Low Target Mean Arterial Pressure in Septic Shock in Critically Ill Cirrhotics (NCT03145168) | Institute of Liver and Biliary Sciences, India | 2018-09-19 |
| The Effect of Rifaximin on Portal Vein Thrombosis (NCT03631147) | Shanghai Zhongshan Hospital | 2018-09-03 |
| Ventriculo-arterial Coupling in Cirrhotics (NCT03948659) | Hospices Civils de Lyon | 2018-08-30 |
| Rôle of the Soluble Endothelial Protein C Receptor in Cirrhosis-associated Hypercoagulability State (EXERCISE) (NCT03625726) | University Hospital, Clermont-Ferrand | 2018-08-03 |
| Medical-economic Evaluation of the Care of Refractory Ascites by Implantation of Alfapump® Device in Cirrhotic Patients (NCT03506893) | University Hospital, Grenoble | 2018-07-17 |
| Mild Hypothermia and Acute Kidney Injury in Liver Transplantation (NCT03534141) | University of California, San Francisco | 2018-07-07 |
| Tadalafil for Erectile Dysfunction in Patients With Cirrhosis (NCT03566914) | Institute of Liver and Biliary Sciences, India | 2018-06-30 |
| Health IT Generated PROs to Improve Outcomes in Cirrhosis (NCT03564626) | Virginia Commonwealth University | 2018-06-22 |
| HEAL STUDY (Hepatic Encephalopathy and Albumin Study) (NCT03585257) | Hunter Holmes Mcguire Veteran Affairs Medical Center | 2018-06-20 |
| A Randomized Controlled Study Evaluating Bariatric Surgery as a Treatment for Severe NASH With Advanced Liver Fibrosis in Non-severe Obese Patients (NCT03472157) | University Hospital, Lille | 2018-06-20 |
| Two Strategies of Primary Prophylaxis of Spontaneous Bacterial Peritonitis in Severe Cirrhotic Patients With Ascites (NCT03069131) | Centre Hospitalier Universitaire de Besancon | 2018-06-05 |
| Assessment of Liver Fibrosis and Prognosis in Chinese Patients With CHB Infection Using STE/STQ Elastography (NCT03530657) | Third Affiliated Hospital, Sun Yat-Sen University | 2018-06-04 |
| Prevalence of Sarcopenia and Undernutrition in Patients With Cirrhosis and Abdominal Hernia (NCT03458845) | University of Sao Paulo | 2018-05-30 |
| Tackling 30-day Readmissions in Patients With Cirrhosis: The SALTYFOOD Trial (NCT03493204) | University of Michigan | 2018-04-24 |
| Study of Two Fasting Procedures Before Gastroscopy: 6 Hours Versus 2 Hours for Clear Fluids (NCT03706846) | Centre Hospitalier Universitaire de Besancon | 2018-04-18 |
| Modified Vagus Nerve-preserving Laparoscopic Splenectomy and Azygoportal Disconnection (NCT03396796) | Yangzhou University | 2018-04-09 |
| Safety, Tolerability and Pharmacodynamics of SYNB1020 (NCT03447730) | Synlogic | 2018-03-19 |
| To Evaluate Efficacy and Safety in TG-2349 Combination With DAG181 (± Ribavirin) in HCV Genotype I Infected Patients (NCT03593447) | Dongguan HEC TaiGen Biopharmaceuticals Co., Ltd. | 2018-03-15 |
| Non-invasive Methods to Predict PHG in Cirrhosis (NCT03513900) | Second Affiliated Hospital of Xi'an Jiaotong University | 2018-03-06 |
| Noninvasive Tests to Predict the Presence of Esophageal Varices in Patients With Liver Cirrhosis (NCT03513887) | Second Affiliated Hospital of Xi'an Jiaotong University | 2018-02-28 |
| Characterization of Methylation Patterns in Hepatocellular Carcinoma (NCT04264754) | Nucleix Ltd. | 2018-02-13 |
| Circulating Cell-free DNA-based Epigenetic Biomarker mSEPT9 for Hepatocellular Carcinoma Detection in Cirrhosis (NCT03311152) | Central Hospital, Nancy, France | 2018-02-12 |
| Fecal Microbial Transplant for Alcohol Misuse in Cirrhosis (NCT03416751) | Hunter Holmes Mcguire Veteran Affairs Medical Center | 2018-02-01 |
| Is Adrenal Insufficiency Under-diagnosed in Hospitalized Cirrhosis Patients? (NCT03368066) | University of Virginia | 2018-01-29 |
| Contrast Enhanced Ultrasound With Lumason in Detecting Liver Cancer in Participants With Cirrhosis (NCT03407001) | M.D. Anderson Cancer Center | 2018-01-12 |
| MRI to Assess the Effect of Terlipressin in Patients With Acute Hepatorenal Syndrome (HRS-AKI) (NCT03483272) | Hvidovre University Hospital | 2018-01-08 |
| Spironolactone on Fibrosis Progrssion-Portal Hypertension(FP-PH)in Cirrhosis (NCT02907749) | Changqing Yang | 2018-01-01 |
| Bariatric Embolization of Arteries in Obese Patients With HCC to Allow Salvage Liver Transplantation (NCT02935478) | St. Louis University | 2017-10-18 |
| HMB for Denutrition in Patients With Cirrhosis (HEPATIC) (NCT03285217) | Instituto Aragones de Ciencias de la Salud | 2017-10-15 |
| Noninvasive Diagnostic Platform for Liver Fibrosis and Portal Hypertension (NCT03277651) | Shanghai Zhongshan Hospital | 2017-10-09 |